Inosita Plus tablet contains Sitagliptin and Metformin which belongs to Biguanide/Dipeptidyl peptidase-4 inhibitors. Metformin is an oral medication that lowers blood glucose by increasing the sensitivity of liver muscle fat and other tissues to the effects of insulin. Increasing the sensitivity of tissues to insulin causes more glucose to be removed from blood and thereby reduces the level of glucose in the blood. In scientific studies metformin reduced the complications of diabetes such as heart disease blindness and kidney disease. Sitagliptin is an oral drug that reduces blood glucose levels in patients with type 2 diabetes.